Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

Oncology Group ◽

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(91)90520-f ◽

1991 ◽

Vol 36 (4) ◽

pp. 352-353

Author(s):

CP Morrow ◽

BN Bundy ◽

RJ Kurman ◽

WT Creasman ◽

P Heller ◽

...

Keyword(s):

Risk Factors ◽

Clinical Stage ◽

Gynecologic Oncology ◽

Stage I ◽

Oncology Group ◽

A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/0090-8258(89)90070-x ◽

1989 ◽

Vol 35 (3) ◽

pp. 314-320 ◽

Cited By ~ 270

Author(s):

G. Delgado ◽

B.N. Bundy ◽

W.C. Fowler ◽

F.B. Stehman ◽

B. Sevin ◽

...

Keyword(s):

Gynecologic Oncology ◽

Squamous Carcinoma ◽

Stage I ◽

Oncology Group ◽

Pathological Study ◽

A perspective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group study

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(90)90152-b ◽

1990 ◽

Vol 32 (4) ◽

pp. 397-397

Author(s):

G Delgado ◽

BN Bundy ◽

WC Fowler ◽

FB Stehman ◽

B Sevin ◽

...

Keyword(s):

Gynecologic Oncology ◽

Squamous Carcinoma ◽

Stage I ◽

Oncology Group ◽

Pathological Study ◽

Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study

International Journal of Gynecological Cancer ◽

10.1111/j.1048-891x.2004.014219.x ◽

2004 ◽

Vol 14 (2) ◽

pp. 341-347 ◽

Cited By ~ 30

Author(s):

H. D. Homesley ◽

G. Boike ◽

G. W. Spiegel

Keyword(s):

Endometrial Carcinoma ◽

Frozen Section ◽

Gynecologic Oncology ◽

Stage I ◽

Oncology Group ◽

Oncology Group Study ◽

Laparoscopic Management

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/0090-8258(90)90166-i ◽

1990 ◽

Vol 36 (2) ◽

pp. 166-171 ◽

Cited By ~ 132

Author(s):

C.Paul Morrow ◽

Brian N. Bundy ◽

Howard D. Homesley ◽

William T. Creasman ◽

Ned B. Hornback ◽

...

Keyword(s):

Radiation Therapy ◽

High Risk ◽

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Stage I ◽

Stage Ii ◽

Oncology Group ◽

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.11.022 ◽

2005 ◽

Vol 96 (3) ◽

pp. 630-634 ◽

Cited By ~ 88

Author(s):

Gregory Sutton ◽

James Kauderer ◽

Linda F. Carson ◽

Samuel S. Lentz ◽

Charles W. Whitney ◽

...

Keyword(s):

Gynecologic Oncology ◽

Stage I ◽

Oncology Group ◽

Oncology Group Study ◽

Resected Stage

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236)

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.08.011 ◽

2015 ◽

Vol 139 (2) ◽

pp. 221-227 ◽

Cited By ~ 11

Author(s):

Linda R. Duska ◽

James J. Java ◽

David E. Cohn ◽

Robert A. Burger

Keyword(s):

Risk Factors ◽

Clinical Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

Front Line ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma ◽

Line Chemotherapy

Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage--A gynecologic oncology group study

Cancer ◽

10.1002/(sici)1097-0142(19960315)77:6<1115::aid-cncr17>3.0.co;2-4 ◽

1996 ◽

Vol 77 (6) ◽

pp. 1115-1121 ◽

Cited By ~ 118

Author(s):

Richard J. Zaino ◽

Robert J. Kurman ◽

Karen L. Diana ◽

C. Paul Morrow

Keyword(s):

Clinical Stage ◽

Endometrial Adenocarcinoma ◽

Gynecologic Oncology ◽

Oncology Group ◽

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Oncology Group ◽

Whole Abdominal Radiotherapy in the Adjuvant Treatment of Patients With Stage III and IV Endometrial Cancer: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70597-6 ◽

2006 ◽

Vol 2006 ◽

pp. 449-452

Author(s):

S.D. Yamada

Keyword(s):

Endometrial Cancer ◽

Adjuvant Treatment ◽

Gynecologic Oncology ◽

Stage Iii ◽

Oncology Group ◽

Oncology Group Study ◽

Abdominal Radiotherapy